openPR Logo
Press release

Bleeding Disorders Market to Surge Amid Rising Awareness and Research Advancements

02-24-2025 12:27 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Bleeding Disorders Market to Surge Amid Rising Awareness

Bleeding Disorders -Market Insights, Size Revenue, Outlook, Overview, and Analysis. The global bleeding disorders market was estimated to be worth USD 14.14 billion in 2023 and is predicted to expand to USD 27.49 billion by 2032, with a CAGR of 7.7% from 2024 to 2032.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/bleeding-disorders-market/request-for-sample

Report Scope:
This comprehensive study provides an accurate overview of the worldwide bleeding disorders industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by type, drug class, and region in the study, which offers a comprehensive picture of the state of the market.

Market Definition:
Bleeding disorders are a classification of conditions that take place when blood cannot clot appropriately. In customary clotting, platelets, a kind of blood cells, stick cohesively and configure a plug at the location of a wounded blood vessel. Proteins in the blood, known as clotting factors, then communicate to configure a fibrin clot, basically a gel plug that secures the platelets in position and permits healing to take place.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/bleeding-disorders-market/request-for-discount-pricing

Drivers and Trends:
• Hemophilia, von Willebrand disease, and other factor dearth are surging. Genetic mutations, an aging population, and altering lifestyles have increased the demand for these products.
• Governments and several nations have initiated agreeable policies to motivate the advancement of the healthcare sector. For instance, in the US, the Orphan Drug Act offers a stimulus for the advancement of cures for infrequent illnesses involving bleeding disorders. These policies have accelerated R&D ventures, which has led to the invention of new therapies.

Top Companies:
Many large businesses are devoting much of their effort to new product releases, partnerships, and market expansion in order to compete effectively. Here are the top companies in the bleeding disorders market:

Novo Nordisk
Bayer AG
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Amgen
Janssen Global Services, LLC

Country-Wise Insights
According to regional research, Asia Pacific dominated the market. The region's growth is aided by the advancement of progressive diagnostic and treatment alternatives such as gene therapy and recombinant clotting elements. Also, North America is anticipated to emerge as the fastest-growing region in the bleeding disorders market.

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/bleeding-disorders-market

Segmental Outlook

Bleeding Disorders, Type Outlook (Revenue - USD Billion, 2019 - 2032)
Hemophilia A
Hemophilia B
Von Willebrand Diseases

Bleeding Disorders, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)
Plasma Derived Coagulation Factor Concentrates
Recombinant Derived Coagulation Factor
Desmopressin
Antifibrinolytics
Fibrin Sealants

Bleeding Disorders Market Report Highlights
1 Hemophilia A Type is anticipated to grow due to the increasing prevalence of hemophilia A and rising demand for novel therapies.

2 Recombinant Coagulation Factor Concentrates segment accounted for the higher growth rate owing to the growing demand for prophylaxis and advancements in manufacturing technology.

More Trending Latest Reports by Polaris Market Research:

Non-Human Primate Pre-clinical studies at Contract Research Organizations Market https://www.polarismarketresearch.com/industry-analysis/non-human-primate-pre-clinical-studies-at-contract-research-organizations-market

Asia Pacific Cell Culture Market https://www.polarismarketresearch.com/industry-analysis/asia-pacific-cell-culture-market

U.S. Ventilators Market https://www.polarismarketresearch.com/industry-analysis/us-ventilators-market

Branded Generics Market https://www.polarismarketresearch.com/industry-analysis/branded-generics-market

Lactation Support Supplements Market https://www.polarismarketresearch.com/industry-analysis/lactation-support-supplements-market

Buccal Fat Removal Market https://www.polarismarketresearch.com/industry-analysis/buccal-fat-removal-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bleeding Disorders Market to Surge Amid Rising Awareness and Research Advancements here

News-ID: 3883421 • Views:

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected to
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach

All 5 Releases


More Releases for Bleeding

Growth Of Bleeding Disorder Testing Market Driven By Increasing Clinical Trials: …
The Bleeding Disorder Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Bleeding Disorder Testing Market? The bleeding disorder testing market size has increased strongly in recent years. It will rise from $14.99 billion in 2024 to $16.23 billion
Rise In The Incidences Of Upper Gastrointestinal Bleeding: Key Factor Driving Th …
The Gastrointestinal Bleeding Treatment Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Gastrointestinal Bleeding Treatment Devices Market Size During the Forecast Period? Recent years have seen a robust growth in the market size of devices used in the treatment of gastrointestinal
Key Trend Reshaping the Bleeding Disorder Testing Market in 2025: Innovative Gen …
What industry-specific factors are fueling the growth of the bleeding disorder testing market? The bleeding disorder testing market is poised for growth, buoyed by the rise in clinical trials. Clinical trials, which test the safety and efficiency of new medical care methods, therapies, drugs, or technology in humans, are increasing due to advancements in medical research, more healthcare innovation investment, and an upsurge in demand for novel treatments and therapies. Bleeding
Transforming the Bleeding Disorder Testing Market in 2025: Growth Of Bleeding Di …
What Is the Expected Size and Growth Rate of the Bleeding Disorder Testing Market? The market size for bleeding disorder testing has witnessed robust growth in recent years. The market value is projected to increase from $14.99 billion in 2024 to a whopping $16.23 billion in 2025, registering a compound annual growth rate (CAGR) of 8.3%. The rate of growth recorded in the historic period is associated with factors such as
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of
Global Cyclic Heavy Menstrual Bleeding Market
Global Cyclic Heavy Menstrual Bleeding Market Heavy menstrual bleeding (HMB) is one of the most common debilitating gynecologic disorders that is affecting women of reproductive age. Increasing incidence rate drives the growth of the cyclic heavy menstrual bleeding market. Rising cases of uterine fibroids and polyps boost the growth of cyclic heavy menstrual bleeding. In addition, effective treatment cost and easy availability of treatment options plays a significant role in